系统化标准化宫腔镜下子宫内膜损伤治疗反复种植失败
这项前瞻性随机对照试验纳入239例既往至少3个新鲜或冻融胚胎移植周期中移植至少4枚优质胚胎未获临床妊娠且年龄小于40岁的反复种植失败患者,随机分为损伤组(n=124)和对照组(n=115)。损伤组在宫腔镜操作中接受子宫内膜损伤,对照组不进行。结果显示损伤组临床妊娠率(25.8% vs 15.6%,P=0.047)、活产率(21.8% vs 12.2%,P=0.049)和种植率(14.2% vs 8.8%,P=0.036)显著高于对照组。
要点
- 宫腔镜下子宫内膜损伤可提高反复种植失败患者的临床妊娠率、活产率和种植率。
- 两组促性腺激素使用时长、总剂量、获卵数、成熟卵数、受精卵数、优质胚胎数、移植胚胎数和内膜厚度均无统计学显著差异。
- 研究排除了存在子宫内膜病变的患者。
核心结论
- 本研究提示子宫内膜损伤对反复种植失败患者有益,可提高种植、临床妊娠和活产的几率。
研究设计与样本
- 前瞻性随机对照试验,纳入239例既往至少3个新鲜或冻融胚胎移植周期中移植至少4枚优质胚胎未获临床妊娠且年龄小于40岁的反复种植失败患者,随机分为损伤组(n=124)和对照组(n=115)。
主要发现
- 损伤组与对照组的促性腺激素使用时长分别为8.23天和8.30天,总剂量分别为2330 IU和2338 IU,获卵数分别为7.03和8.21,成熟卵数分别为5.27和6.02,受精卵数分别为4.19和4.55,优质胚胎数分别为2.07和2.43,移植胚胎数分别为1.97和1.93,子宫内膜厚度分别为9.04 mm和9.35 mm,以上指标两组间均无统计学显著差异。
- 损伤组临床妊娠率为25.8%,对照组为15.6%(P=0.047),差异显著 favoring 损伤组。
- 损伤组活产率为21.8%,对照组为12.2%(P=0.049),差异显著 favoring 损伤组。
- 损伤组种植率为14.2%,对照组为8.8%(P=0.036),差异显著 favoring 损伤组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: To investigate the effect of hysteroscopic endometrial injury for treatment of recurrent implantation failure (RIF). DESIGN: This prospective and randomized controlled trial included 239 patients who had failed to achieve a clinical pregnancy after the transfer of at least four good-quality embryos in a minimum of three fresh or frozen-thawed embryo transfer cycles and were under the age of 40 years, who were randomized into two groups. The injury group (n = 124) received endometrial injury during their hysteroscopic procedure, whereas the control group (n = 115) did not. Patients who had endometrial pathologies were excluded from the study. RESULTS: There were no statistically significant differences in duration of gonadotrophin use (8.23 versus 8.30 days), total dose of gonadotrophins (2330 versus 2338 IU), number of oocytes (7.03 versus 8.21), number of mature oocytes (5.27 versus 6.02), number of fertilized oocytes (4.19 versus 4.55), number of good-quality embryos (2.07 versus 2.43), number of embryos transferred (1.97 versus 1.93) or endometrial thickness (9.04 versus 9.35 mm) between the injury group and control group, respectively. Clinical pregnancy rates (25.8% versus 15.6%, P = 0.047), live birth rates (21.8% versus 12.2%, P = 0.049) and implantation rates (14.2% versus 8.8%, P = 0.036) were significantly different, favouring the injury group. CONCLUSION: This study suggests that endometrial injury is beneficial in RIF patients to increase the odds of implantation, clinical pregnancy and live birth.
引用
- Gürgan T, Kalem Z, Kalem MN, et al. Systematic and standardized hysteroscopic endometrial injury for treatment of recurrent implantation failure. Reprod Biomed Online. 2019. PMID: 31405721. doi:10.1016/j.rbmo.2019.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。